Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Raftilose® Synergy 1 Shown to Protect Against Colon Cancer
An EU-funded project designed to evaluate whether synbiotics can reduce the risk of colorectal cancer has found that Raftilose®Synergy1 combined with probiotics does have a positive effect; results of the research show that by taking a synbiotic each day, the damage to cell DNA can be significantly reduced.
- Study Indicates That GliSODin® May Provide Significant Protection Against UV Radiation-induced Skin Changes
In double-blind, placebo controlled study, UV skin burn (actinic erythema) was induced on the inner-forearms of healthy subjects before supplementation with GliSODin or placebo, and each week for four weeks during supplementation; color of the skin was measured by chromometry, and changes in skin due to inflammation were assessed by videocapillaroscopy.
- Study Indicates That GliSODin® May Provide Significant Protection Against UV Radiation-induced Skin Changes
In double-blind, placebo controlled study, UV skin burn (actinic erythema) was induced on the inner-forearms of healthy subjects before supplementation with GliSODin or placebo, and each week for four weeks during supplementation; color of the skin was measured by chromometry, and changes in skin due to inflammation were assessed by videocapillaroscopy.
- Study Indicates That GliSODin® May Provide Significant Protection Against UV Radiation-induced Skin Changes
In double-blind, placebo controlled study, UV skin burn (actinic erythema) was induced on the inner-forearms of healthy subjects before supplementation with GliSODin or placebo, and each week for four weeks during supplementation; color of the skin was measured by chromometry, and changes in skin due to inflammation were assessed by videocapillaroscopy.
- Study Indicates That GliSODin® May Provide Significant Protection Against UV Radiation-induced Skin Changes
In double-blind, placebo controlled study, UV skin burn (actinic erythema) was induced on the inner-forearms of healthy subjects before supplementation with GliSODin or placebo, and each week for four weeks during supplementation; color of the skin was measured by chromometry, and changes in skin due to inflammation were assessed by videocapillaroscopy.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Irritable Bowel Syndrome (IBS) Study - Recruiting Completed
Company announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
- Irritable Bowel Syndrome (IBS) Study - Recruiting Completed
Company announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
- Irritable Bowel Syndrome (IBS) Study - Recruiting Completed
Company announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
- Irritable Bowel Syndrome (IBS) Study - Recruiting Completed
Company announces completion of recruiting for their Irritable Bowel Syndrome (IBS) Clinical Trial utilizing ImmunoLin.
- Natural Extract for Treating MRSA Presented
Research on allicin presented at American Society for Microbiology meeting in Atlanta.
- Natural Extract for Treating MRSA Presented
Research on allicin presented at American Society for Microbiology meeting in Atlanta.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Omega-3 offers hope for new anti-breast cancer drugs
Research published today in the journal Breast Cancer Research indicates that Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibit cancer cell migration by 50% and significantly reduce their metastatic activity.
- Raisins As A Functional Food For Oral Health
Researchers at the University of Illinois at Chicago School of Dentistry have determined that compounds in raisins suppress bacteria that cause cavities and gum disease. According to research presented at the meeting of the American Society for Microbiology, five compounds (oleanolic acid, oleanolic aldehyde, betulin, betulinic acid and 5-(hydroxymethyl)-2-furfural) seem to make teeth and gums healthier, in the case of oleanic acid, by slowing growth of a cavity causing bacteria and inhibiting the bacteria from sticking to surfaces.
- Raisins As A Functional Food For Oral Health
Researchers at the University of Illinois at Chicago School of Dentistry have determined that compounds in raisins suppress bacteria that cause cavities and gum disease. According to research presented at the meeting of the American Society for Microbiology, five compounds (oleanolic acid, oleanolic aldehyde, betulin, betulinic acid and 5-(hydroxymethyl)-2-furfural) seem to make teeth and gums healthier, in the case of oleanic acid, by slowing growth of a cavity causing bacteria and inhibiting the bacteria from sticking to surfaces.
- Raisins As A Functional Food For Oral Health
Researchers at the University of Illinois at Chicago School of Dentistry have determined that compounds in raisins suppress bacteria that cause cavities and gum disease. According to research presented at the meeting of the American Society for Microbiology, five compounds (oleanolic acid, oleanolic aldehyde, betulin, betulinic acid and 5-(hydroxymethyl)-2-furfural) seem to make teeth and gums healthier, in the case of oleanic acid, by slowing growth of a cavity causing bacteria and inhibiting the bacteria from sticking to surfaces.
- Raisins As A Functional Food For Oral Health
Researchers at the University of Illinois at Chicago School of Dentistry have determined that compounds in raisins suppress bacteria that cause cavities and gum disease. According to research presented at the meeting of the American Society for Microbiology, five compounds (oleanolic acid, oleanolic aldehyde, betulin, betulinic acid and 5-(hydroxymethyl)-2-furfural) seem to make teeth and gums healthier, in the case of oleanic acid, by slowing growth of a cavity causing bacteria and inhibiting the bacteria from sticking to surfaces.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- Advitech Announces Completion of 2nd Study on XP-828L For Psoriasis
multi-centre, randomized double-blind, placebo-controlled study was conducted over a 112-day period; final results to be released July 5, 2005.
- Advitech Announces Completion of 2nd Study on XP-828L For Psoriasis
multi-centre, randomized double-blind, placebo-controlled study was conducted over a 112-day period; final results to be released July 5, 2005.
- Advitech Announces Completion of 2nd Study on XP-828L For Psoriasis
multi-centre, randomized double-blind, placebo-controlled study was conducted over a 112-day period; final results to be released July 5, 2005.
- Advitech Announces Completion of 2nd Study on XP-828L For Psoriasis
multi-centre, randomized double-blind, placebo-controlled study was conducted over a 112-day period; final results to be released July 5, 2005.
- The Quigley Corporation Announces Results of Animal Model Inflammation Studies of Its QR440 Botanical, Anti-Inflammatory Compound
Company has obtained results from a series of In-Vivo (animal model) inflammation studies, finds Delayed-Type- Hypersensitivity T cell response reduced in mice, and granulyte movement to inflammation site also reduced.
- The Quigley Corporation Announces Results of Animal Model Inflammation Studies of Its QR440 Botanical, Anti-Inflammatory Compound
Company has obtained results from a series of In-Vivo (animal model) inflammation studies, finds Delayed-Type- Hypersensitivity T cell response reduced in mice, and granulyte movement to inflammation site also reduced.
- Ladislav Pataki to Head Research and Development at Ameritech International Corp.
Ladislav Pataki, PhD, CSc, ISASc has been appointed Director of Research and Development at Ameritech International Corp. Dr. Pataki developed both the PowerLean and NutrLife health and wellness lines of products recently purchased by Ameritech.
- Ladislav Pataki to Head Research and Development at Ameritech International Corp.
Ladislav Pataki, PhD, CSc, ISASc has been appointed Director of Research and Development at Ameritech International Corp. Dr. Pataki developed both the PowerLean and NutrLife health and wellness lines of products recently purchased by Ameritech.
- Ladislav Pataki to Head Research and Development at Ameritech International Corp.
Ladislav Pataki, PhD, CSc, ISASc has been appointed Director of Research and Development at Ameritech International Corp. Dr. Pataki developed both the PowerLean and NutrLife health and wellness lines of products recently purchased by Ameritech.
- Ladislav Pataki to Head Research and Development at Ameritech International Corp.
Ladislav Pataki, PhD, CSc, ISASc has been appointed Director of Research and Development at Ameritech International Corp. Dr. Pataki developed both the PowerLean and NutrLife health and wellness lines of products recently purchased by Ameritech.
- Ladislav Pataki to Head Research and Development at Ameritech International Corp.
Ladislav Pataki, PhD, CSc, ISASc has been appointed Director of Research and Development at Ameritech International Corp. Dr. Pataki developed both the PowerLean and NutrLife health and wellness lines of products recently purchased by Ameritech.
- Ladislav Pataki to Head Research and Development at Ameritech International Corp.
Ladislav Pataki, PhD, CSc, ISASc has been appointed Director of Research and Development at Ameritech International Corp. Dr. Pataki developed both the PowerLean and NutrLife health and wellness lines of products recently purchased by Ameritech.
- Ladislav Pataki to Head Research and Development at Ameritech International Corp.
Ladislav Pataki, PhD, CSc, ISASc has been appointed Director of Research and Development at Ameritech International Corp. Dr. Pataki developed both the PowerLean and NutrLife health and wellness lines of products recently purchased by Ameritech.
- Ladislav Pataki to Head Research and Development at Ameritech International Corp.
Ladislav Pataki, PhD, CSc, ISASc has been appointed Director of Research and Development at Ameritech International Corp. Dr. Pataki developed both the PowerLean and NutrLife health and wellness lines of products recently purchased by Ameritech.
- Advitech Announces Positive Results of XP-828L Study In Psoriasis
Company reports positive results from its recently completed randomized, multi-center, double-blind, placebo-controlled clinical trial of XP-828L, confirming efficacy and safety.
- Advitech Announces Positive Results of XP-828L Study In Psoriasis
Company reports positive results from its recently completed randomized, multi-center, double-blind, placebo-controlled clinical trial of XP-828L, confirming efficacy and safety.
- Advitech Announces Positive Results of XP-828L Study In Psoriasis
Company reports positive results from its recently completed randomized, multi-center, double-blind, placebo-controlled clinical trial of XP-828L, confirming efficacy and safety.
- Advitech Announces Positive Results of XP-828L Study In Psoriasis
Company reports positive results from its recently completed randomized, multi-center, double-blind, placebo-controlled clinical trial of XP-828L, confirming efficacy and safety.
- Saw Palmetto and Nettle Root Combination Effective for Prostate and Urinary Problems in Elderly Men
Randomized, double-blind, placebo-controlled trial was conducted by researchers at the Institute of Urology in Moscow on 257 men, and examined the effectiveness of an herbal blend combining saw palmetto and nettle root extracts in treating urinary tract difficulties in older men.
- Saw Palmetto and Nettle Root Combination Effective for Prostate and Urinary Problems in Elderly Men
Randomized, double-blind, placebo-controlled trial was conducted by researchers at the Institute of Urology in Moscow on 257 men, and examined the effectiveness of an herbal blend combining saw palmetto and nettle root extracts in treating urinary tract difficulties in older men.
- Saw Palmetto and Nettle Root Combination Effective for Prostate and Urinary Problems in Elderly Men
Randomized, double-blind, placebo-controlled trial was conducted by researchers at the Institute of Urology in Moscow on 257 men, and examined the effectiveness of an herbal blend combining saw palmetto and nettle root extracts in treating urinary tract difficulties in older men.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- NutraCea Announces Results of Open Label Trial at University of New Mexico School of Medicine
Company announces results of the second phase open label clinical trial conducted at the University of New Mexico (UNM) School of Medicine; in 39 patients studied, researchers observe 12.31% reduction in total cholesterol and a 10.54% reduction of LDL cholesterol.
- NutraCea Announces Results of Open Label Trial at University of New Mexico School of Medicine
Company announces results of the second phase open label clinical trial conducted at the University of New Mexico (UNM) School of Medicine; in 39 patients studied, researchers observe 12.31% reduction in total cholesterol and a 10.54% reduction of LDL cholesterol.
- New Clinical Study Further Evidence: Walnuts Protective for People with Type 2 Diabetes
Study published in the July 2005 issue of the Journal of the American Dietetic Association indicates that the intake of 30 grams of walnuts a day in conjunction with 350g of oily fish a week enabled achievement of recommendations on the type of fat in an energy-controlled diet for the management of diabetes.
- New Clinical Study Further Evidence: Walnuts Protective for People with Type 2 Diabetes
Study published in the July 2005 issue of the Journal of the American Dietetic Association indicates that the intake of 30 grams of walnuts a day in conjunction with 350g of oily fish a week enabled achievement of recommendations on the type of fat in an energy-controlled diet for the management of diabetes.
- New Clinical Study Further Evidence: Walnuts Protective for People with Type 2 Diabetes
Study published in the July 2005 issue of the Journal of the American Dietetic Association indicates that the intake of 30 grams of walnuts a day in conjunction with 350g of oily fish a week enabled achievement of recommendations on the type of fat in an energy-controlled diet for the management of diabetes.
- Study Shows Supplementing With Martek DHA(TM) While Breastfeeding Improves Psychomotor Skills in Toddlers
Double-blind, placebo-controlled study published this month in the American Journal of Clinical Nutrition indicates that children of DHA-supplemented moms scored significantly higher on the Bayley Psychomotor Development Index (PDI), when compared to the children of the non-supplemented breastfeeding moms.
- Study Shows Supplementing With Martek DHA(TM) While Breastfeeding Improves Psychomotor Skills in Toddlers
Double-blind, placebo-controlled study published this month in the American Journal of Clinical Nutrition indicates that children of DHA-supplemented moms scored significantly higher on the Bayley Psychomotor Development Index (PDI), when compared to the children of the non-supplemented breastfeeding moms.
- Study Shows Supplementing With Martek DHA(TM) While Breastfeeding Improves Psychomotor Skills in Toddlers
Double-blind, placebo-controlled study published this month in the American Journal of Clinical Nutrition indicates that children of DHA-supplemented moms scored significantly higher on the Bayley Psychomotor Development Index (PDI), when compared to the children of the non-supplemented breastfeeding moms.
- Study Shows Supplementing With Martek DHA(TM) While Breastfeeding Improves Psychomotor Skills in Toddlers
Double-blind, placebo-controlled study published this month in the American Journal of Clinical Nutrition indicates that children of DHA-supplemented moms scored significantly higher on the Bayley Psychomotor Development Index (PDI), when compared to the children of the non-supplemented breastfeeding moms.
- Mannatech Announces Results of Independent Study on Ambrotose AO(R)
Company sponsored dose-response study, conducted by the Australian Centre for Complementary Medicine Education and Research (ACCMER), indicated a significant increase in the antioxidant levels in the blood after supplementation with the company's antioxidant product, Ambrotose AO(R).
- Mannatech Announces Results of Independent Study on Ambrotose AO(R)
Company sponsored dose-response study, conducted by the Australian Centre for Complementary Medicine Education and Research (ACCMER), indicated a significant increase in the antioxidant levels in the blood after supplementation with the company's antioxidant product, Ambrotose AO(R).
- Study: Pycnogenol(R) Can Help Prevent Leg, Ankle Swelling on Long Airline Flights
double-blind, placebo controlled study published in the July 2005 issue of Clinical and Applied Thrombosis/Hemostasis tested in-flight ankle swelling for 169 participants and found that untreated passengers showed increased ankle swelling almost twice as high as in the group of passengers supplemented with Pycnogenol®.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Data Supported UK Food Standards Agency Confirmation of Safety
PURCHASE, NY, Thursday, June 23, 2005 – Nutrition 21, Inc., (NASDAQ: NXXI) today announced results of a new study reaffirming the safety of Chromax® chromium picolinate to be published in an upcoming issue of Mutation Research Genetic Toxicology and Environmental Mutagenesis, the leading peer-reviewed genotoxicity journal said. The study is currently available online at http://dx.doi.org/10.1016/j.mrgentox.2005.04.001.
The results found that Chromax did not cause genetic damage in hamster ovary cells. The study was conducted at the request of the United Kingdom (UK) Food Standards Agency (FSA) to repeat a previously published study showing DNA damage. The prior study was not performed under International Conference on Harmonization (ICH) Guidelines and did not use commercially available chromium picolinate.
“When Chromax was tested using internationally accepted guidelines, there was no damage to DNA resulting in gene mutations, even at doses higher than those used in earlier studies,” said Ron Slesinski, PhD, DABT, lead research and senior scientist at ENVIRON Health Sciences, and President of the Regulatory & Safety Specialty Section of the Society of Toxicology. “The new findings are consistent with many previous studies showing chromium picolinate is safe.”
The body of scientific evidence supporting chromium picolinate’s safety includes more than 50 studies, including human clinical trials with more than 2,000 participants, numerous animal studies on thousands of animals, and cellular testing. Chromium picolinate has been recognized as safe by many of the world’s leading government and private research institutions including the UK FSA and the Institute of Medicine.
“This study adds to the existing preponderance of human and animal evidence that has for years confirmed that Chromax is safe,” said James Komorowski, MS, VP of Technical Services and Scientific Affairs, Nutrition 21. “The results of this study were critical in supporting the UK FSA decision to allow for continued sales of Chromax in the UK.” Chromax chromium picolinate received GRAS (Generally Recognized as Safe) affirmation for use in nutritional bars and beverages in June 2002 based on an extensive safety review later published in Food and Chemical Toxicology in 2004.
Chromium is an essential trace mineral critical to proper insulin function and necessary for carbohydrate, fat and protein metabolism. Chromium, which is found naturally in foods in small amounts, is not well absorbed by the body. Chromium, in the form of chromium picolinate, has been used as a supplement ingredient for more than a decade in leading U.S. vitamin brands. An estimated 10 million people consume supplements with chromium each year. Safety research conducted over the past several years has confirmed no significant adverse effects of chromium picolinate when ingested at any dose.
# # #
About Nutrition 21
Nutrition 21 is a nutritional bioscience company and the maker of chromium-based supplements with health benefits substantiated by clinical research. The company markets Chromax chromium picolinate, which is the most-studied form of the essential mineral chromium. Chromax is available for purchase at www.chromax.com. Nutrition 21 also developed Diachrome, which is available through diabetes educators or at www.diachrome.com. Nutrition 21 holds 36 patents for nutrition products and uses, 27 of which are for chromium compounds and their uses. More information is available at www.nutrition21.com.
CONTACT
Stacey Antine, MS, RD, 914-701-4567 |